Literature DB >> 19940125

Matriptase activation, an early cellular response to acidosis.

I-Chu Tseng1, Han Xu, Feng-Pai Chou, Gong Li, Alexander P Vazzano, Joseph P Y Kao, Michael D Johnson, Chen-Yong Lin.   

Abstract

Extracellular acidosis often rapidly causes intracellular acidification, alters ion channel activities, and activates G protein-coupled receptors. In this report, we demonstrated a novel cellular response to acidosis: induction of the zymogen activation of matriptase. Acid-induced matriptase activation is ubiquitous among epithelial and carcinoma cells and is characterized by rapid onset, fast kinetics, and the magnitude of activation seen. Trace amounts of activated matriptase can be detected 1 min after cells are exposed to pH 6.0 buffer, and the vast majority of latent matriptase within the cells is converted to activated matriptase within 20 min. Matriptase activation may be a direct response to proton exposure because acid-induced matriptase activation also occurs in an in vitro, cell-free setting in which intracellular signaling molecules and ion channel activities are largely absent. Acid-induced matriptase activation takes place both on the cell surface and inside the cells, likely due to the parallel intracellular acidification that activates intracellular matriptase. Following matriptase activation, the active enzyme is immediately inhibited by binding to hepatocyte growth factor activator inhibitor 1, resulting in stable matriptase-hepatocyte growth factor activator inhibitor 1 complexes that are rapidly secreted. As an early response to acidosis, matriptase activation can also be induced by perturbation of intracellular pH homeostasis by 5-(N-methyl-N-isobutyl)-amiloride and 5-(N-ethyl-N-isopropyl)-amiloride, both of which inhibit Na(+)/H(+) exchangers, and diisothiocyanostilbene-2,2'-disulfonic acid, which can inhibit other acid-base ion channels. This study uncovers a novel mechanism regulating proteolysis in epithelial and carcinoma cells, and also demonstrates that a likely function of matriptase is as an early response to acidosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19940125      PMCID: PMC2823413          DOI: 10.1074/jbc.M109.055640

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Basolateral Na(+)/HCO(3)(-) cotransport activity is regulated by the dissociable Na(+)/H(+) exchanger regulatory factor.

Authors:  A A Bernardo; F T Kear; A V Santos; J Ma; D Steplock; R B Robey; E J Weinman
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

2.  Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity.

Authors:  C Y Lin; J Anders; M Johnson; Q A Sang; R B Dickson
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

3.  Characterization of a novel, membrane-bound, 80-kDa matrix-degrading protease from human breast cancer cells. Monoclonal antibody production, isolation, and localization.

Authors:  C Y Lin; J K Wang; J Torri; L Dou; Q A Sang; R B Dickson
Journal:  J Biol Chem       Date:  1997-04-04       Impact factor: 5.157

4.  Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue.

Authors:  T Takeuchi; M A Shuman; C S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains.

Authors:  M G Kim; C Chen; M S Lyu; E G Cho; D Park; C Kozak; R H Schwartz
Journal:  Immunogenetics       Date:  1999-05       Impact factor: 2.846

6.  Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk.

Authors:  C Y Lin; J Anders; M Johnson; R B Dickson
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

7.  Gastrointestinal pH profiles in patients with inflammatory bowel disease.

Authors:  A G Press; I A Hauptmann; L Hauptmann; B Fuchs; M Fuchs; K Ewe; G Ramadori
Journal:  Aliment Pharmacol Ther       Date:  1998-07       Impact factor: 8.171

8.  Analysis of pH, pO2 and pCO2 in drainage fluid allows for rapid detection of infectious complications during the follow-up period after abdominal surgery.

Authors:  H P Simmen; H Battaglia; P Giovanoli; J Blaser
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

9.  Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing.

Authors:  T Mauro; W M Holleran; S Grayson; W N Gao; M Q Man; E Kriehuber; M Behne; K R Feingold; P M Elias
Journal:  Arch Dermatol Res       Date:  1998-04       Impact factor: 3.017

10.  Amiloride analog stimulation of short-circuit current in larval frog skin epithelium.

Authors:  T Cox
Journal:  J Exp Biol       Date:  1997-12       Impact factor: 3.312

View more
  37 in total

1.  Targeting zymogen activation to control the matriptase-prostasin proteolytic cascade.

Authors:  Zhenghong Xu; Ya-Wen Chen; Aruna Battu; Paul Wilder; David Weber; Wenbo Yu; Alexander D Mackerell; Li-Mei Chen; Karl X Chai; Michael D Johnson; Chen-Yong Lin
Journal:  J Med Chem       Date:  2011-10-12       Impact factor: 7.446

2.  Matriptase activation and shedding through PDGF-D-mediated extracellular acidosis.

Authors:  Abdo J Najy; Gregory Dyson; Bhanu P Jena; Chen-Yong Lin; Hyeong-Reh C Kim
Journal:  Am J Physiol Cell Physiol       Date:  2015-07-08       Impact factor: 4.249

3.  Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors.

Authors:  Trine Tamberg; Zebin Hong; Daphné De Schepper; Signe Skovbjerg; Daniel M Dupont; Lars Vitved; Christine R Schar; Karsten Skjoedt; Lotte K Vogel; Jan K Jensen
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

4.  Roles of CUB and LDL receptor class A domain repeats of a transmembrane serine protease matriptase in its zymogen activation.

Authors:  Kuniyo Inouye; Marie Tomoishi; Makoto Yasumoto; Yuka Miyake; Kenji Kojima; Satoshi Tsuzuki; Tohru Fushiki
Journal:  J Biochem       Date:  2012-10-03       Impact factor: 3.387

5.  Mechanisms for the control of matriptase activity in the absence of sufficient HAI-1.

Authors:  Han Xu; Zhenghong Xu; I-Chu Tseng; Feng-Pai Chou; Ya-Wen Chen; Jehng-Kang Wang; Michael D Johnson; Hiroaki Kataoka; Chen-Yong Lin
Journal:  Am J Physiol Cell Physiol       Date:  2011-10-26       Impact factor: 4.249

6.  Increased matriptase zymogen activation in inflammatory skin disorders.

Authors:  Cheng-Jueng Chen; Bai-Yao Wu; Pai-In Tsao; Chi-Yung Chen; Mei-Hsuan Wu; Yee Lam E Chan; Herng-Sheng Lee; Michael D Johnson; Richard L Eckert; Ya-Wen Chen; Fengpai Chou; Jehng-Kang Wang; Chen-Yong Lin
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-01       Impact factor: 4.249

7.  Matriptase expression and zymogen activation in human pilosebaceous unit.

Authors:  Bai-Yao Wu; Shiao-Pieng Lee; Hui-Chung Hsiao; Han Chiu; Chi-Yung Chen; Yee Hui Yeo; Herng-Sheng Lee; Ya-Wen Chen; Malvika Kaul; Hiroaki Kataoka; Michael D Johnson; Jehng-Kang Wang; Chen-Yong Lin
Journal:  J Histochem Cytochem       Date:  2013-09-04       Impact factor: 2.479

8.  Imbalanced matriptase pericellular proteolysis contributes to the pathogenesis of malignant B-cell lymphomas.

Authors:  Feng-Pai Chou; Ya-Wen Chen; Xianfeng F Zhao; Zijun Y Xu-Monette; Ken H Young; Ronald B Gartenhaus; Jehng-Kang Wang; Hiroaki Kataoka; Annie H Zuo; Robert J Barndt; Michael Johnson; Chen-Yong Lin
Journal:  Am J Pathol       Date:  2013-10       Impact factor: 4.307

9.  Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.

Authors:  Kazuyo Kohama; Makiko Kawaguchi; Tsuyoshi Fukushima; Chen-Yong Lin; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2012-12-18       Impact factor: 4.174

10.  Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1.

Authors:  Baoyu Zhao; Cai Yuan; Rui Li; Dan Qu; Mingdong Huang; Jacky Chi Ki Ngo
Journal:  J Biol Chem       Date:  2013-02-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.